Search clinical trials for: rituximab and lenalidomide
Total 270322 results
-
CelgeneCompletedMyelodysplastic SyndromesUnited States, Germany
-
University Hospital, ToulouseCelgene; Intergroupe Francophone du MyelomeCompleted
-
The Cleveland ClinicNational Cancer Institute (NCI)CompletedKidney CancerUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingRecurrent Mantle Cell Lymphoma | Mantle Cell Lymphoma | CCND1 Positive | CCND2 Positive | CCND3 Positive | CD20 Positive | Refractory Mantle Cell LymphomaUnited States
-
University of Wisconsin, MadisonGenentech, Inc.; Celgene CorporationCompletedLymphoma, Non-Hodgkin | Small Lymphocytic Lymphoma | Lymphoid LeukemiaUnited States
-
Weill Medical College of Cornell UniversityCelgene CorporationTerminatedWaldenstrom MacroglobulinemiaUnited States
-
Hoffmann-La RocheCompletedNon-Hodgkin's LymphomaFrance
-
University Hospital, ToulouseDana-Farber Cancer Institute; Celgene Corporation; Janssen-Cilag Ltd.Completed
-
Johns Hopkins All Children's HospitalTerminatedCentral Nervous System TumorsUnited States
-
CelgeneCompletedMultiple MyelomaUkraine, Russian Federation
-
King's College Hospital NHS TrustCompleted
-
National Cancer Institute (NCI)CompletedBrain and Central Nervous System TumorsUnited States
-
M.D. Anderson Cancer CenterCelgene CorporationCompleted
-
University Health Network, TorontoCelgene CorporationCompleted
-
Yale UniversityCelgene CorporationTerminatedChronic Lymphocytic LeukemiaUnited States
-
National Institutes of Health Clinical Center (CC)National Cancer Institute (NCI)CompletedLymphoma | Small Intestine Cancer | Unspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Celgene CorporationCompletedRadiculopathyUnited States
-
University of WashingtonMerck Sharp & Dohme LLCActive, not recruitingRecurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Recurrent Follicular Lymphoma | Refractory Follicular LymphomaUnited States
-
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.Not yet recruitingB-cell Non-Hodgkin's Lymphoma
-
National Cancer Institute (NCI)CompletedAdult Acute Megakaryoblastic Leukemia (M7) | Adult Acute Minimally Differentiated Myeloid Leukemia (M0) | Adult Acute Monoblastic Leukemia (M5a) | Adult Acute Monocytic Leukemia (M5b) | Adult Acute Myeloblastic Leukemia With Maturation (M2) | Adult Acute Myeloblastic Leukemia Without Maturation... and other conditionsUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteCelgeneCompleted
-
Samyang Biopharmaceuticals CorporationChungnam National University HospitalCompleted
-
National Research Center for Hematology, RussiaRecruitingPrimary CNS LymphomaRussian Federation
-
Sun Yat-sen UniversityNot yet recruiting
-
Mayo ClinicNational Cancer Institute (NCI)Active, not recruiting
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI)CompletedLymphomaUnited States
-
Lymphoma Study AssociationAmgenTerminatedDiffuse Large Cell LymphomaFrance, Belgium, Switzerland
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedLymphomaUnited States, Canada
-
Dong-A University HospitalCompleted
-
University of California, San FranciscoCompletedLymphoma | Brain and Central Nervous System Tumors
-
Assistance Publique - Hôpitaux de ParisCompletedThrombotic Thrombocytopenic PurpuraFrance
-
Neufeld, Ellis J, MD, PhDGenentech, Inc.; Biogen; Glaser Pediatric Research Network; Terrana ITP Research...CompletedImmune Thrombocytopenic Purpura (ITP) | Idiopathic Thrombocytopenic Purpura (ITP)United States
-
National Pediatric Neuroinflammation Organization...Genentech, Inc.CompletedAtaxia | Myoclonus | Opsoclonus-myoclonus Syndrome | OpsoclonusUnited States
-
Gustave Roussy, Cancer Campus, Grand ParisUnknown
-
Nathan DenlingerBristol-Myers SquibbRecruitingB-Cell Non-Hodgkin Lymphoma-Recurrent | Diffuse Large B-Cell Lymphoma-Recurrent | Follicular Lymphoma-Recurrent | High Grade B-Cell Lymphoma-Recurrent | Primary Mediastinal Large B-Cell Lymphoma-Recurrent | Transformed Indolent B-Cell Non-Hodgkin Lymphoma to Diffuse Large B-Cell Lymphoma-Recurrent and other conditionsUnited States
-
Swiss Group for Clinical Cancer ResearchCompleted
-
University Hospital HeidelbergUnknownCD20+ Aggressive Lymphoma, Mantle Cell LymphomaGermany
-
University of Wisconsin, MadisonGenentech, Inc.WithdrawnEnd Stage Renal DiseaseUnited States
-
PETHEMA FoundationCompletedAcute Lymphoblastic Leukemia | Burkitt's LymphomaSpain
-
Genentech, Inc.CompletedMultiple SclerosisUnited States
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI)CompletedLymphomaUnited States, Puerto Rico, South Africa
-
BiogenCompletedNon-Hodgkin's LymphomaSweden, Czech Republic, France, Russian Federation, Turkey, United Kingdom, Germany, Lithuania, Romania, United States, Austria
-
Rambam Health Care CampusTechnion, Israel Institute of TechnologyUnknown
-
University of Alabama at BirminghamCompletedPurpura, Thrombocytopenic, IdiopathicUnited States
-
Charite University, Berlin, GermanyHoffmann-La RocheUnknownAnkylosing SpondylitisGermany
-
Cedars-Sinai Medical CenterGenentech, Inc.; BiogenCompletedKidney TransplantUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingRecurrent Mantle Cell Lymphoma | Refractory Mantle Cell LymphomaUnited States
-
Novartis PharmaceuticalsBristol-Myers SquibbRecruitingNon-Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma, Follicular Lymphoma, Mantle Cell Lymphoma, Marginal Zone LymphomaUnited States, Germany, Italy, Korea, Republic of, Spain, Singapore, China, Japan, Australia
-
Beijing Friendship HospitalRecruiting
-
German CLL Study GroupCelgeneCompletedChronic Lymphocytic LeukemiaGermany